Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Endocrinology · Classic Congenital Adrenal Hyperplasia

Building Your Care Team and Preparing for the First Visit

At a Glance

Managing Congenital Adrenal Hyperplasia (CAH) requires a multidisciplinary team led by an endocrinologist. To prepare for your first visit, gather your newborn screening report, genetic testing results, and lab history to help establish a highly accurate, lifelong care plan.

Building a strong medical team is one of the most important steps in managing Congenital Adrenal Hyperplasia (CAH). Because the condition affects multiple systems—hormones, growth, development, and psychology—it is best managed by a multidisciplinary team [1][2].

The Core Specialist: The Endocrinologist

The “quarterback” of your team will be an endocrinologist (pediatric or adult). They are responsible for balancing your (or your child’s) hormones and monitoring growth [1][3].

When choosing an endocrinologist, look for expertise in:

  • Precision Testing: They should use LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry). This is a highly sensitive lab method that is far more accurate for CAH than traditional “immunoassays” [4][5].
  • Lifespan Management: A high-quality provider will have a clear plan for monitoring complications like metabolic health, bone density, and (in males) adrenal rest tumors [6][7].

The DSD Multidisciplinary Team

For females with virilization (genital anatomy that looks different), a DSD (Differences of Sex Development) team is essential [8][9]. This team typically includes:

  • Pediatric Urologists or Gynecologists: Experts in managing anatomical differences [10][11].
  • Psychologists or Social Workers: To provide support for the emotional and social aspects of the diagnosis [12][13].
  • Genetic Counselors: To help you understand the genetic basis of the condition and risks for future children [14][15].

Preparing for the First Visit

Your first consultation is the foundation of your care. To make the most of it, bring the following records [16][17]:

  1. Newborn Screening (NBS) Report: Try to get the “raw data” that shows the exact 17-OHP value and the timing of the heel prick (how many hours after birth) [18][19].
  2. Symptom Timeline: For older patients diagnosed later in childhood (particularly males), bring a timeline of when symptoms like rapid growth, early pubic hair, or skin changes began [20][21].
  3. Genetic Testing Results: The specific CYP21A2 mutation report is vital for confirming the type of CAH [14][15].
  4. Lab History: Any previous blood tests for 17-OHP, androstenedione, or electrolytes (sodium and potassium) [22][17].
  5. Birth History: Details like birth weight and gestational age, which help doctors interpret early hormone levels [23][19].

Ongoing Support

Specialized care is not just about doctors. Many high-volume centers provide access to endocrine nurses who are experts in training families on “sick day rules” and emergency injections [24][25]. Don’t hesitate to ask if your clinic has a dedicated nurse educator or a peer support group for families living with CAH [26][27].

Common questions in this guide

What type of doctor treats congenital adrenal hyperplasia?
The primary specialist for CAH is an endocrinologist, who can be a pediatric or adult provider. They act as the team leader to balance hormones, monitor growth, and manage overall metabolic health.
What is a DSD multidisciplinary team?
A Differences of Sex Development (DSD) team usually includes urologists, gynecologists, psychologists, and genetic counselors. This team works together to manage anatomical differences and provide essential emotional support for patients and families.
What medical records should I bring to my first CAH appointment?
You should bring the raw data from your newborn screening report, a timeline of when symptoms began, genetic testing results confirming the CYP21A2 mutation, previous blood lab history, and detailed birth history.
What is the best blood test method for monitoring CAH?
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) is the most highly recommended method. It is far more sensitive and accurate for monitoring CAH hormones than traditional immunoassay tests.
Why do I need a nurse educator for CAH?
A specialized endocrine nurse educator teaches patients and families essential survival skills. They provide hands-on training for emergency stress dose injections and explain how to follow sick day protocols when the patient is ill.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with classic CAH do you currently manage, and are you part of a larger multidisciplinary team?
  2. 2.Does the lab you use for hormone testing utilize LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) for more accurate results?
  3. 3.Who is the primary contact on the team if I have an urgent question about a fever or stress dosing after hours?
  4. 4.(For females) Can you connect us with a DSD (Differences of Sex Development) team, including specialists in urology and psychology?
  5. 5.Do you have a dedicated nurse educator who can walk us through the emergency injection technique and 'sick day' protocols?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (27)
  1. 1

    Caring for Patients With Congenital Adrenal Hyperplasia Throughout the Lifespan.

    Zwayne N, Chawla R, van Leeuwen K

    Obstetrics and gynecology 2023; (142(2)):257-268 doi:10.1097/AOG.0000000000005263.

    PMID: 37473408
  2. 2

    Treatment and Follow-up of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency in Childhood and Adolescence

    Peltek Kendirci HN, Ünal E, Dündar İ, et al.

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):12-22 doi:10.4274/jcrpe.galenos.2024.2024-6-26-S.

    PMID: 39713876
  3. 3

    Management challenges and therapeutic advances in congenital adrenal hyperplasia.

    Mallappa A, Merke DP

    Nature reviews. Endocrinology 2022; (18(6)):337-352 doi:10.1038/s41574-022-00655-w.

    PMID: 35411073
  4. 4

    The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives.

    de Hora M, Heather N, Webster D, et al.

    Frontiers in endocrinology 2023; (14()):1226284 doi:10.3389/fendo.2023.1226284.

    PMID: 37850096
  5. 5

    Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

    Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, et al.

    Endocrine reviews 2022; (43(1)):91-159 doi:10.1210/endrev/bnab016.

    PMID: 33961029
  6. 6

    Epidemiology and Long-Term Adverse Outcomes in Korean Patients with Congenital Adrenal Hyperplasia: A Nationwide Study.

    Kim JH, Choi S, Lee YA, et al.

    Endocrinology and metabolism (Seoul, Korea) 2022; (37(1)):138-147 doi:10.3803/EnM.2021.1328.

    PMID: 35255606
  7. 7

    Testicular Adrenal Rest Tumors: Current Insights on Prevalence, Characteristics, Origin, and Treatment.

    Engels M, Span PN, van Herwaarden AE, et al.

    Endocrine reviews 2019; (40(4)):973-987 doi:10.1210/er.2018-00258.

    PMID: 30882882
  8. 8

    Clinical, Etiological and Laboratory Profile of Children with Disorders of Sexual Development (DSD)-Experience from a Tertiary Pediatric Endocrine Unit in Western India.

    Jahagirdar R, Khadilkar V, Deshpande R, Lohiya N

    Indian journal of endocrinology and metabolism 2021; (25(1)):48-53 doi:10.4103/ijem.IJEM_520_20.

    PMID: 34386394
  9. 9

    Society for Endocrinology UK Guidance on the initial evaluation of a suspected difference or disorder of sex development (Revised 2021).

    Ahmed SF, Achermann J, Alderson J, et al.

    Clinical endocrinology 2021; (95(6)):818-840 doi:10.1111/cen.14528.

    PMID: 34031907
  10. 10

    Antenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency and Congenital Adrenal Hyperplasia Screening in Newborns

    Yavaş Abalı Z, Kurnaz E, Güran T

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):33-43 doi:10.4274/jcrpe.galenos.2024.2024-6-10-S.

    PMID: 39713885
  11. 11

    Syrian females with congenital adrenal hyperplasia: a case series.

    Dehneh N, Jarjour R, Idelbi S, et al.

    Journal of medical case reports 2022; (16(1)):371 doi:10.1186/s13256-022-03609-y.

    PMID: 36242011
  12. 12

    Timing and Outcome Concerns regarding Feminizing Genitoplasty from the Perspective of Egyptian Families of Girls with Virilized External Genitalia.

    Marei MM, Fares AE, Musa N, et al.

    Hormone research in paediatrics 2016; (85(1)):49-57 doi:10.1159/000442200.

    PMID: 26645541
  13. 13

    Screening for Anxiety and Depression in Children with Congenital Adrenal Hyperplasia

    Jacob M, Lin-Su K, Catarozoli C, et al.

    Journal of clinical research in pediatric endocrinology 2023; (15(4)):406-416 doi:10.4274/jcrpe.galenos.2023.2023-2-10.

    PMID: 37470306
  14. 14

    Nonclassic Congenital Adrenal Hyperplasia: What Do Endocrinologists Need to Know?

    Jha S, Turcu AF

    Endocrinology and metabolism clinics of North America 2021; (50(1)):151-165 doi:10.1016/j.ecl.2020.10.008.

    PMID: 33518183
  15. 15

    Long-Read Sequencing Solves Complex Structure of CYP21A2 in a Large 21-Hydroxylase Deficiency Cohort.

    Wang R, Luo X, Sun Y, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(2)):406-416 doi:10.1210/clinem/dgae519.

    PMID: 39049755
  16. 16

    Divergent Gender Identity in a Phenotypic Male with 46XX Karyotype Caused by a Mutation in CYP21A2 Gene with Congenital Adrenal Hyperplasia.

    Kumar KCP, Banik S, Joy P, Sahoo S

    International journal of applied & basic medical research 2024; (14(2)):134-137 doi:10.4103/ijabmr.ijabmr_473_23.

    PMID: 38912360
  17. 17

    Congenital adrenal hyperplasia with salt-wasting crisis and arrhythmia: a case study.

    Canlas JF, Ponmani C

    BMJ case reports 2019; (12(1)) doi:10.1136/bcr-2018-227565.

    PMID: 30700462
  18. 18

    Best Practice for Identification of Classical 21-Hydroxylase Deficiency Should Include 21 Deoxycortisol Analysis with Appropriate Isomeric Steroid Separation.

    Greaves RF, Kumar M, Mawad N, et al.

    International journal of neonatal screening 2023; (9(4)) doi:10.3390/ijns9040058.

    PMID: 37873849
  19. 19

    Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.

    Hayashi GY, Carvalho DF, de Miranda MC, et al.

    Clinical endocrinology 2017; (86(4)):480-487 doi:10.1111/cen.13292.

    PMID: 27978607
  20. 20

    Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH).

    Hoyer-Kuhn H, Eckert AJ, Binder G, et al.

    The Journal of clinical endocrinology and metabolism 2023; (108(11)):e1199-e1204 doi:10.1210/clinem/dgad307.

    PMID: 37256841
  21. 21

    Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia.

    van der Linde AAA, Schönbeck Y, van der Kamp HJ, et al.

    Archives of disease in childhood 2019; (104(7)):653-657 doi:10.1136/archdischild-2018-315972.

    PMID: 30712004
  22. 22

    Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry.

    Lawrence N, Bacila I, Dawson J, et al.

    Clinical endocrinology 2022; (97(5)):551-561 doi:10.1111/cen.14796.

    PMID: 35781728
  23. 23

    Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.

    de Hora MR, Heather NL, Webster D, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(9)):e3390-e3399 doi:10.1210/clinem/dgab383.

    PMID: 34058748
  24. 24

    Treatment and Prevention of Adrenal Crisis and Family Education

    Çamtosun E, Sangün Ö

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):80-92 doi:10.4274/jcrpe.galenos.2024.2024-6-12-S.

    PMID: 39713905
  25. 25

    The Key to Adrenal Insufficiency Education: Repetition, Repetition, Repetition.

    Keil MF, Van Ryzin C

    Pediatric endocrinology reviews : PER 2017; (14(Suppl 2)):448-453 doi:10.17458/per.vol14.2017.kr.keyadrenalinsufficiency.

    PMID: 28647949
  26. 26

    Toward Improving the Transition of Patients With Congenital Adrenal Hyperplasia From Pediatrics to Adult Healthcare in Japan.

    Takasawa K, Kashimada K

    Frontiers in pediatrics 2022; (10()):936944 doi:10.3389/fped.2022.936944.

    PMID: 35799687
  27. 27

    Elective Reconstruction for Children With Congenital Adrenal Hyperplasia: Evaluating Association of Familial Characteristics.

    Heller K, Madura G, Nawara N, et al.

    The Journal of surgical research 2025; (313()):291-296 doi:10.1016/j.jss.2025.06.029.

    PMID: 40680596

This page provides information on building a care team for CAH for educational purposes only. Always consult your endocrinologist or a qualified healthcare provider for personal medical advice and treatment plans.

Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.